Wall Street Journal -- WASHINGTON—A federal judge held off a decision on whether to bar a generic version of Sanofi-Aventis SA's big-selling drug Lovenox, in a lengthy court hearing Tuesday that highlighted the stakes for a new generation of copycat drugs.
